Caris Launches World's First ChromoSeq for Myeloid Malignancies
Caris Life Sciences launches ChromoSeq, the world’s first whole genome and transcriptome assay for myeloid malignancies, offering deeper insights and faster diagnosis.
Caris ChromoSeq | 06/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy